Table 1

Clinical characteristics in 82 patients with endocrine tumours of the duodenopancreatic area

No (%)
Diagnosis
 Non-functioning tumour44  (54)
 Gastrinoma23 (28)
 Calcitonin-secreting tumour7 (8)
 Glucagonoma4 (5)
 Insulinoma3 (3.5)
 Somatostatinoma1
Size of the primary tumour
 < 3 cm34 (41.5)
 ⩾ 3 cm48 (58.5)
Primary tumour site1-150
 Pancreas62 (75.5)
 Duodenum13 (16)
 Peri-pancreatic lymph nodes7 (8.5)
Patients with MEN I1-160 7 (8.5)
Patients with metastases
 Liver49 (60)
 Lymph nodes52 (63.5)
 Other1-165 15 (18.5)
Progression of liver metastases
 Yes27 (55)
 No4 (8)
 Non evaluated18 (37)
Locoregional involvement
 Yes26 (32)
 No56 (68)
Tumour cell differentiation
 Good64 (78)
 Poor9 (11)
 Non evaluated9 (11)
Complete resection of the primary tumour
 Yes42 (51)
 No40 (49)
  • 1-150 Multiple tumours were observed in the duodenum of two patients with gastrinomas and in the pancreas of one patient with an insulinoma.

  • 1-160 Multiple endocrine neoplasia type I.

  • 1-165 Bones n=8, peritoneum n=5, lungs n=4, brain n=2, adrenal glands n=2 and skin n=1.